ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STANLEY SMITH M.D.

Internal Medicine

29,858

$1.43M

1150
949 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

BRENT SAVELLI MD

Internal Medicine

29,156

$1.52M

984
664 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

THOMAS FERRARI M.D.

Internal Medicine

29,126

$1.65M

1018
546 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

JOSEPH HERREN MD

Internal Medicine

28,835

$1.96M

837
727 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $56

DAVID BOSSHARDT M.D.

Internal Medicine

28,597

$1.47M

1061
721 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

ROBERT STOUT MD

Internal Medicine

28,510

$1.09M

941
761 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

BRYAN HOOKER MD

Internal Medicine

28,455

$1.47M

953
665 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

SAQIB NAZIR M.D.

Internal Medicine

28,401

$1.31M

794
384 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

KEVIN NAPIER M.D.

Internal Medicine

28,350

$1.45M

1109
896 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

STEPHEN CORSE MD

Internal Medicine

27,868

$1.6M

880
737 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

ANIL MODI MD

Internal Medicine

27,843

$1.28M

787
657 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

DAVID PAINE M.D.

Internal Medicine

27,731

$1.29M

805
627 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

CHARLES ROMAN D.O.

Internal Medicine

27,554

$1.4M

1300
844 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

VIRGINIA JONES MD

Internal Medicine

26,659

$1.27M

691
508 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

PETER ALLOTEY MD

Internal Medicine

26,588

$1.05M

783
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

MUHAMMAD REHAN M.D.

Internal Medicine

25,959

$1.64M

572
352 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $56

JONATHAN BUSBEE M.D.

Internal Medicine

25,651

$1.17M

1006
697 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

KAUSHIK AMIN MD

Internal Medicine

25,549

$1.48M

806
482 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

ANTHONY CAPTAIN M.D.

Internal Medicine

25,535

$1.45M

604
419 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

AMAR SINGH MD

Internal Medicine

25,214

$2.22M

818
546 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$88
Average prescription price

Avg: $56

MAGED ABDELMALIK M.D.

Internal Medicine

24,652

$1.34M

546
412 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

F. CONNER MD

Internal Medicine

24,632

$1.47M

819
647 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

SAURBH DESAI MD

Internal Medicine

24,556

$1.2M

874
676 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

KIRKLAND DODSON MD

Internal Medicine

24,483

$1.14M

607
480 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

JAMES MCGOWAN M.D.

Internal Medicine

24,306

$1.22M

690
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank